Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina

Revista Argentina de Microbiologia

Volumn 39, Issue 3, 2007, Pages 156-160

  Fernandez Canigia L ^a   Castello, L ^a   Di Martino, A ^a   Greco, G ^a   Legaria, M C ^a   Litterio, M ^a   Predari, S C ^a   Rollet, R ^a   Rossetti, A ^a   Carloni, G ^a   Sarchi, M I ^b   Bianchini, H ^a  

^a Asociacion Argentina de Microbiologia   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Antianaerobic drugs; Bacteroides fragilis group; Susceptibility

Indexed keywords

AMPICILLIN; CEFOXITIN; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; PIPERACILLIN; SULTAMICILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARGENTINA; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BACTEROIDES FRAGILIS; MONITORING; NONHUMAN;

AMPICILLIN; AMPICILLIN RESISTANCE; ARGENTINA; BACTEROIDES; BACTEROIDES FRAGILIS; BACTEROIDES INFECTIONS; CEFOXITIN; CLINDAMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; IMIPENEM; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; PIPERACILLIN; RETROSPECTIVE STUDIES; SPECIES SPECIFICITY; SULBACTAM; URBAN POPULATION;

EID: 35448995278     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bianchini H, Berenstein P, Notario R, Litterio M, Greco G, Hardie N, et al. Estudio multicéntrico de la sensibilidad de bacterias anaerobias en la Argentina. Infect Microbiol Clín 1994; 6: 7-16.
2. Bianchini H. Methods for susceptibility testing in anaerobes: when and how they should be used. Anaerobe 1999; 5: 417-20.
3. Betriu C, Culebras E, Gómez M, Rodríguez-Avial I, Picazo JJ. In vitro activity of tigecycline against Bacteroides species. J Antimicrob Chemother 2005; 56: 349-52.
4. Cuchural GJ Jr, Malamy MH, Tally FP. Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis. Antimicrob Agents Chemother 1986; 30: 645-8.
5. Hecht DW. Anaerobes: antibiotic resistance. Clinical significance, and the role of susceptibility testing. Anaerobe 2006; 12: 115-21.
6. Litterio M, Bianchini H, Carloni G, Di Martino A, Fernández Canigia L, Greco G, et al. Actividad «in vitro» de 10 antimicrobianos trente a bacterias anaerobias. Estudio multicéntrico 1999-2002. Rev Argent Microbiol 2004; 36: 130-5.
7. Litterio M, Castello L, Rollet R, Di Martino A, Greco G, Fernández Canigia L, et al. Susceptibility of anaerobic gram-negative rods to trovafloxacin. Drugs 1999; 58 Suppl 2: 193-4.
8. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria; 3rd Approved standard, 1993; M11-A3. Villanova, Pa, USA.
9. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria; 4th Approved standard, 1997; M11-A4. Villanova, Pa, USA.
10. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria; 5th Approved standard, 2001; M11-A5. Wayne, Pa, USA.
11. Nguyen MH, Yu VL, Morris AJ, McDermott L, Wagener MW, Harrell L, et al. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis 2000; 30: 870-6.
12. Podglajen I, Breuil J, Casin I, Collatz E. Genotypic identification of two groups within the species Bacteroides fragilis by ribotyping and by analysis of PCR-generated fragment patterns and insertion sequence content. J Bacteriol 1995; 177: 5270-5.
13. Rotimi VO, Khoursheed M, Brazier JS, Jamal WY, Khodakhast FB. Bacteroides species highly resistant to metronidazole: an emerging clinical problem? Clin Microbiol Infect 1999; 5: 166-9.
14. Salonen JH, Eerola E, Meurman O. Clinical significance and outcome of anaerobic bacteremia. Clin Infect Dis 1997; 26: 1413-7.
15. Snydman DR, Jacobus NV, McDermott LA, Ruthazer R, Goldstein EJ, Finegold SM, et al. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends for 1997-2000. Clin Infect Dis 2002; 35: S126-34.
16. Teng L-J, Hsueh P-R, Tsai J-C, Liaw S-J, Ho S-W, Luh K-T. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan. Antimicrob Agents Chemother 2002; 46: 2908-13.